Up-regulation of the lymphatic marker podoplanin in human squamous cell carcinomas and germ cell tumors

Up-regulation of the lymphatic marker podoplanin in human squamous cell carcinomas and germ cell tumors

Bibliographic Details
Main Authors:	Schacht, V, Dadras, S, Johnson, L, Jackson, D, Hong, Y, Detmar, M
Format:	Conference item
Published:	2004

Similar Items

Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.
by: Schacht, V, et al.
Published: (2005)

Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma
by: ., Nur Rahadiani, et al.
Published: (2010)

Expression of Podoplanin in Laryngeal Squamous Cell Carcinoma and Dysplasia
by: Badawia Bayoumy Ibrahim, et al.
Published: (2017-05-01)

Postnatal deletion of podoplanin in lymphatic endothelium results in blood filling of the lymphatic system and impairs dendritic cell migration to lymph nodes
by: Bianchi, R, et al.
Published: (2016)

Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas
by: Fresno Manuel F, et al.
Published: (2010-03-01)

Podoplanin+ tumor lymphatics are rate limiting for breast cancer metastasis.
by: Yang Chen, et al.
Published: (2018-12-01)

Interplay between Podoplanin, CD44s and CD44v in Squamous Carcinoma Cells
by: Lucía Montero-Montero, et al.
Published: (2020-09-01)

Comparing Immunohistochemical Expression of Podoplanin between Oral Squamous Cell Carcinoma and Normal Oral Mucosa
by: Samareh Jazayeri, et al.
Published: (2022-07-01)

Lymphangiogenesis in melanoma, squamous cell carcinoma and breast carcinoma
by: Skobe, M, et al.
Published: (2001)

Modulation of VEGF-induced migration and network formation by lymphatic endothelial cells: Roles of platelets and podoplanin
by: Stacey A. Langan, et al.
Published: (2018-07-01)

Proliferating Lymphatic Endothelial Cells as a Prognostic Marker in Head and Neck Squamous Cell Carcinoma
by: Cristina Stefania Dumitru, et al.
Published: (2022-08-01)

Immunoexpression of Podoplanin in Leukoplakia and Oral Squamous Cell Carcinoma and its Correlation with Survival: A Research Protocol
by: Samiha Jameel Ahmed Khan, et al.
Published: (2022-12-01)

Association of the co-expression of SOX2 and Podoplanin in the progression of oral squamous cell carcinomas - an immunohistochemical study
by: Sonali Pradhan, et al.

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
by: Cursiefen, C, et al.
Published: (2002)

Lymphatic marker podoplanin/D2-40 in human advanced cirrhotic liver- Re-evaluations of microlymphatic abnormalities
by: Yoshimura Kazunori, et al.
Published: (2010-11-01)

Keratinocyte-Expressed Podoplanin is Dispensable for Multi-Step Skin Carcinogenesis
by: Marko Sesartić, et al.
Published: (2020-06-01)

Correlation between Podoplanin-positive Lymphatic Microvessel Density  and CT Characteristics of Non-small Cell Lung Cancer
by: Hui ZHOU, et al.
Published: (2012-01-01)

An important role of podoplanin in hair follicle growth.
by: Sun-Young Yoon, et al.
Published: (2019-01-01)

Podoplanin immunopositive lymphatic vessels at the implant interface in a rat model of osteoporotic fractures.
by: Katrin Susanne Lips, et al.
Published: (2013-01-01)

Roles of Podoplanin in Malignant Progression of Tumor
by: Hiroyuki Suzuki, et al.
Published: (2022-02-01)

Prognostic Value of Podoplanin in Various Tumors
by: Xiaohang Wang PhD, et al.
Published: (2021-09-01)

Near-infrared-II Ag2S quantum dot probes targeting podoplanin enhance immunotherapy in oral squamous cell carcinoma
by: Honggang Xiong, et al.
Published: (2024-01-01)

Renal cells activate the platelet receptor CLEC-2 through podoplanin.
by: Christou, C, et al.
Published: (2008)

Renal cells activate the platelet receptor CLEC-2 through podoplanin
by: Christou, C, et al.
Published: (2008)

Advances in the study of tumor markers for intracranial germ cell tumors
by: Lei HAN, et al.
Published: (2020-04-01)

Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
by: Maula, S, et al.
Published: (2003)

Lymphatic metastasis is predicted by gene expression signature of the primary tumor in squamous cell carcinoma of the oral cavity
by: Wei, S, et al.
Published: (2004)

Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
by: Xu, H, et al.
Published: (2004)

Podoplanin-positive dilated lymphatic vessels in duodenum associates with three-month mortality in patients with cirrhosis
by: Pinky Juneja, et al.
Published: (2023-05-01)

Periostin – an unexplored tumor marker of oral squamous cell carcinoma
by: Khushboo Desai, et al.
Published: (2020-12-01)

Podoplanin as an Attractive Target of CAR T Cell Therapy
by: Masazumi Waseda, et al.
Published: (2020-08-01)

Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis
by: Liya Hu, et al.
Published: (2020-05-01)

Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis
by: Ce Li, et al.
Published: (2023-07-01)

Lymphatic vessel invasion detected by the endothelial lymphatic marker D2-40 (podoplanin) is predictive of regional lymph node status and an independent prognostic factor in patients with resected esophageal cancer
by: Jerzy Laudański, et al.
Published: (2011-04-01)

Prognostic value of podoplanin expression in intratumoral stroma and neoplastic cells of uterine cervical carcinomas
by: Filomena M Carvalho, et al.
Published: (2010-01-01)

Syk and Src Family Kinases Regulate C-type Lectin Receptor 2 (CLEC-2)-mediated Clustering of Podoplanin and Platelet Adhesion to Lymphatic Endothelial Cells.
by: Pollitt, A, et al.
Published: (2014)

Cell traffic and the lymphatic endothelium.
by: Johnson, L, et al.
Published: (2008)

Tumor-infiltrating podoplanin+ cells in gastric cancer: clinical outcomes and association with immune contexture
by: Xin Liu, et al.
Published: (2020-01-01)

Tumor markers in oral squamous cell carcinoma as an adjunct to diagnosis: An insight
by: Monika Negi, et al.
Published: (2018-01-01)

Tumor Recurrence and Follow-Up Intervals in Oral Squamous Cell Carcinoma
by: Sebastian Blatt, et al.
Published: (2022-11-01)